News | Artificial Intelligence | October 18, 2019

MaxQ AI's Intracranial Hemorrhage Software to be Integrated on Philips CT Systems

MaxQ AI’s Accipio ICH and stroke software will be integrated on Philips CT systems and will be available to hospitals and radiology departments throughout the U.S. and EU

October 18, 2019 — Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that its Accipio intracranial hemorrhage (ICH) and stroke software will be integrated on Philips’ computed tomography (CT) systems. The integration of Accipio’s AI-powered solutions into Philips CT systems will support the detection of ICH to augment caregivers in identifying and prioritizing patients suffering from stroke, traumatic brain injury, head trauma and other life-threatening conditions.

MaxQ AI’s Accipio ICH and Stroke Platform utilizes deep learning technologies to analyze medical imaging data such as non-contrast head CT images. The results provide deep clinical insight and actionable data in minutes that will enable physicians across the world to make faster assessments in any location, at any time. Accipio Ix enables automatic identification and prioritization of non-contrast head CT images with suspected ICH. Accipio Ax provides automatic slice-level annotation of suspected ICH. Both Accipio Ix and Ax are U.S. Food and Drug Administration (FDA)-cleared and CE approved.

The Accipio platform will be available with new Philips CT systems and as an upgrade to previously installed Philips CT systems throughout U.S. and EU markets. The first deployments are expected to take place in 2020.

The integration with Philips is MaxQ AI’s second such agreement in 2019 following a similar deal with GE Healthcare in January. The company announced its first distribution agreement with Samsung NeuroLogica in November 2018, shortly after Accipio IX received FDA clearance.

Read the article “MaxQ AI Receives FDA Clearance for Accipio Ix Intracranial Hemorrhage Platform“

MaxQ AI will be demonstrating the company’s full suite of Accipio solutions during the upcoming Radiological Society of North America (RSNA) 2019 Annual Meeting, Dec. 1-6 in Chicago. Accipio will also be on display at the Philips exhibit.

For more information: www.maxq.ai, www.usa.philips.com/healthcare

Related Content

Chest CT imaging of patient. #coronavirus #nCoV2019 #2019nCoV #COVID19

Examples of typical chest CT findings compatible with COVID-19 pneumonia in patients with epidemiological and clinical presentation suspicious for COVID-19 infection. This image is part of the original research, Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR, published Feb. 19, 2020, in Radiology Online.

News | Computed Tomography (CT) | February 19, 2020

New Research Advocates for Chest CT in COVID-19 Diagnosis

February 19, 2020 — In new research

Sponsored Content | Videos | Enterprise Imaging | February 19, 2020

itnTV "Conversations": Expanding Server-side Technology Across the Enterprise

Bill Lacy, vice president, Medical Informatics at FUJIFILM Medic...

Sponsored Content | Videos | Flat Panel Displays | February 19, 2020

VIDEO: See What Matters in 20/20

EIZO medical monitors were showcased recently at RSN...

Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship

News | Radiology Business | February 19, 2020

ITN Named a Finalist in the 66th Annual Jesse H. Neal Awards

February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced

Novel Coronavirus 2019-nCoV Pneumonia. #coronavirus #nCoV2019 #2019nCoV #COVID19

Image by _freakwave_ from Pixabay

News | Computed Tomography (CT) | February 16, 2020

FDA Statement on Actions in Response to 2019 Novel Coronavirus

February 16, 2020 — The following statement was issued by the U.S.

negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. #coronavirus #nCoV2019 #2019nCoV #COVID19

Figure 1: Patient flowchart. Of 167 patients screened, 5 (3%) had negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. Chart courtesy of Radiology

Feature | Computed Tomography (CT) | February 14, 2020

How Radiologists are Analyzing the 2019-nCoV Coronavirus Pneumonia Epidemic

As the 2019-nCoV Pneumonia is taking the world by storm, researchers have found a possible way to predict this virus

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

The Caption Guidance software uses artificial intelligence to guide users to get optimal cardiac ultrasound images in a point of care ultrasound (POCUS) setting.

News | Artificial Intelligence | February 13, 2020

FDA Clears Artificial Intelligence to Guide User for Optimal Cardiac Ultrasound Imaging

February 13, 2020 — The U.S.

Mobile devices proved both reliable and accurate for the clinical decision to administer IV thrombolysis in patients with acute stroke

Appearance of same unenhanced CT scan on three reading systems: E-2620 monitor (Barco) (A), Galaxy S8 Plus (Samsung) smartphone (B) and ThinkPad T460s laptop computer (Lenovo) (C).

News | Computed Tomography (CT) | February 12, 2020

Smartphone, Laptop Prove Reliable and Accurate for Acute Stroke Decision

February 12, 2020 — Mobile devices proved both reliable and accurate for the clinical decision to administer IV throm

Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.

News | Image Guided Radiation Therapy (IGRT) | February 11, 2020

Varian Receives FDA 510(k) Clearance for Ethos Therapy

February 11, 2020 — Varian announced it has received FDA 510(k) c

CT image of Novel Coronavirus 2019-nCoV from the Radiology article showing a baseline CT image of a 75 year old male with multiple patchy areas of pure ground glass opacity (GGO) and GGO with reticular and/or interlobular septal thickening. Follow-up CT images on day 3 after admission show an overlap of organizing pneumonia with diffuse alveolar damage in that it is more diffuse and associated with underlying reticulation. Read more and see 15 more images from novel coronavirus patients in the article.

An image from the Radiology article showing a baseline CT image of a 75 year old male with multiple patchy areas of pure ground glass opacity (GGO) and GGO with reticular and/or interlobular septal thickening. Follow-up CT images on day 3 after admission show an overlap of organizing pneumonia with diffuse alveolar damage in that it is more diffuse and associated with underlying reticulation. Read more and see 15 more images from novel coronavirus patients in the article.

Feature | Computed Tomography (CT) | February 11, 2020

Chest CT Findings of Patients Infected With Novel Coronavirus 2019-nCoV Pneumonia

February 11, 2020 — The Radiological Society of North America (RSNA) jo